Contrasting OrthoPediatrics (KIDS) & Its Peers

OrthoPediatrics (NASDAQ: KIDS) is one of 19 public companies in the “Medical Devices & Implants” industry, but how does it compare to its peers? We will compare OrthoPediatrics to related businesses based on the strength of its risk, dividends, institutional ownership, valuation, profitability, analyst recommendations and earnings.


This table compares OrthoPediatrics and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
OrthoPediatrics N/A N/A N/A
OrthoPediatrics Competitors -101.23% -92.70% -30.32%

Institutional & Insider Ownership

54.8% of shares of all “Medical Devices & Implants” companies are held by institutional investors. 11.9% of shares of all “Medical Devices & Implants” companies are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares OrthoPediatrics and its peers revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
OrthoPediatrics N/A N/A N/A
OrthoPediatrics Competitors $1.67 billion $207.58 million 80.89

OrthoPediatrics’ peers have higher revenue and earnings than OrthoPediatrics.

Analyst Recommendations

This is a breakdown of current ratings and target prices for OrthoPediatrics and its peers, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OrthoPediatrics 0 0 4 0 3.00
OrthoPediatrics Competitors 110 728 1026 10 2.50

OrthoPediatrics presently has a consensus target price of $23.67, indicating a potential upside of 28.41%. As a group, “Medical Devices & Implants” companies have a potential upside of 36.86%. Given OrthoPediatrics’ peers higher possible upside, analysts plainly believe OrthoPediatrics has less favorable growth aspects than its peers.

About OrthoPediatrics

OrthoPediatrics Corp. is a United States-based medical device company. The Company designs, develops and commercializes orthopedic implants and instruments to meet the specialized needs of pediatric surgeons and their patients. It operates through the OrthoPediatrics segment, which designs, develops and markets implants and devices for children with orthopedic problems. Its products include RESPONSE Spinal Deformity System, PediNail Intramedullary Nail System, PediLoc Plating Systems, ACL Reconstruction System, Locking Cannulated Blade (LCB) plate system, Locking Proximal Femur (LPF) plate system, PediFlex Flexible Nailing System, PediFrag, PediLoc Extension Osteotomy Plate (PLEO), PediLoc Femur Locking Plate System, PediLoc Tibia Locking Plate System, PediPlates system and Spica Table. It markets over 20 surgical systems that serve approximately three categories within pediatric orthopedic market, including trauma and deformity, complex spine and anterior cruciate ligament reconstruct

What are top analysts saying about OrthoPediatrics Corp.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for OrthoPediatrics Corp. and related companies.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit